Anticonvulsant activity of bioflavonoid gossypin

Bangladesh Journal of Pharmacology

Volumn 4, Issue 1, 2009, Pages 51-54

  Rasilingam, Duraisami ^a   Duraisamy, Srinivasan ^b   Subramanian, Ramanswamy ^c  

^a NANDHA COLLEGE OF PHARMACY   (India)

^b ANNAMALAI UNIVERSITY   (India)

^c Aarupadai Veedu Medical College and Hospital   (India)

Author keywords

Anticonvulsant; Bioflavonoid; Gossypin; Pentelenetetrazole; Strychnine

Indexed keywords

4 AMINOBUTYRIC ACID; GLYCINE; GOSSYPINE; PENTETRAZOLE; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ELECTRIC SHOCK; MOUSE; NONHUMAN; TONIC SEIZURE;

EID: 68049111588     PISSN: 1991007X     EISSN: None     Source Type: Journal    
DOI: 10.3329/bjp.v4i1.1081     Document Type: Article

References (21)

1. Achliya GS, Wadodkar SG, Darle AK. Evaluation of CNS activity of Bramhi Ghrita. Indian J Pharmacol. 2005; 37: 33-36.
2. Babu BH, Jayaram HN, Nair MG, Ajay Kumar KB, Padikkala J. Free radical scavenging, antitumor and anti-carcinogenic activity of gossypin. J Exp Clin Cancer Res. 2003; 6: 2281-89.
3. De Sarro A, Cecchetti V, Fravolini V, Naccari F, Tabarrini O, De Sarro G. Effects of novel β-desfluroquinolones and classic quinolones on pentelenetetrazole-induced seizures in mice. Antimicrob Agents Chemother. 1999; 43: 1729-36.
4. Gale MK. GABA and epilepsy basic concepts from preclinical research. Epilepsia 1992; 33 Suppl: S3-12.
5. Gupta YK, Malhotra J. Adenosinergic system as an endogenous anticonvulsant mechanism. J Physiol Pharmacol. 1997; 41; 329-43.
6. Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988; 2; 145-81. http://dx.doi.org/10.1016/0920-1211(88)90054-X PMid:3058469
7. Loscher W. Animal models of epilepsy for the development of antileptogenic and disease modifying drugs: A comparison of pharmacology of kindling and poststatus epilepticus models of temporal lobe epilepsy. Epilepsy Res. 1999; 50: 105-23. http://dx.doi.org/10.1016/ S0920-1211(02)00073-6 PMid:12151122
8. Mattson RH. Drug treatment of partial epilepsy. Adv Neurol. 1992; 57: 643-50.
9. Meldrum BS. GABA agonists as antiepileptic agents. Advan Biochem Psycopharmacol. 1981; 26: 207-17.
10. McNamara JO. Drugs effective in the therapy of the epilepsies. In: Goodman and Gillman's The pharmacological basis of therapeutics. Hardman, JG, Limbird LE (eds). 10th ed. New York, McGraw-Hill, 2001, pp 521-39.
11. Porter RJ, Meldrum BS. Antiseizure drugs. In: Basic and clinical pharmacology. Katzung BG (ed). New York, Lange Medical Books/ McGraw-Hill, 2001, pp 403-17.
12. Salahdeen HM, Yemitan OK. Neuropharmacological effects of aqueous leaf extract of Bryophyllum pinnatum in mice. African J Bio Med Res. 2006; 9: 101-07.
13. Sayin U, Cengiz S, Altug T. Vigabatin as an anticonvulsant against penteletetrazole seizures. Pharmacol Res. 1993; 28: 325-31. http://dx.doi.org/10.1006/phrs.1993.1134 PMid:8140032
14. Vidyasagar J, Srinivas M, Nagulu M, Venkatasam A, Udyakiran B, Krishna DR. Protein binding study of gossypin by equilibrium dialysis. Curr Trends Biotech Phar. 2008; 2: 396-401.
15. Viola H, Wasowski C, Levidestein M, Wolfmane, Silveria R, Dajas F, Medina JH, Paladini AC. Apigenin, a componant of Marlicaria recutita flowers, is a central benzodiazepine receptors-legand with anxiolytic effects. Planta Med. 1995; 61: 213-16.
16. Westmoreland BF, Benarroch EE, Dube JR, Regan TJ, Sandok BA. Medical neurosciences. Mayo Foundation Rochester 1994, pp 307-12.
17. White HS. Clinical significance of animal seizure models and mechanism of action, studies of potential antiepileptic drugs. Epilepsia 1995; 38 Suppl: S9-17.
18. WHO. Epilepsy: Etiology, epidemiology and prognosis. www.who.int/entire/ mediacentre/factsheets/fs165/en/-25k-16jan2006.
19. Wolfman C, Viola H, Paladini A, Dajas F, Media JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passifloara coerulea. Pharmacol Biochem Behav. 1994; 47: 1-4. http://dx.doi.org/10.1016/0091-3057(94)90103-1
20. Yemitan OK, Adeymi OO. CNS depressant activity of Lecaniodisurs cupanioides. Fitoterpia 2005; 76: 412-18. http://dx.doi.org/ 10.1016/j.fitote.2005.02.010 PMid:15955638
21. Yemitan OK, Salahdeen HM. Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. Fitoterpia 2005; 76: 187-93. http://dx.doi.org/10.1016/j.fitote.2004.11.009 PMid:15752629